{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:04:47Z","timestamp":1787097887159,"version":"build-2736575974"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12031-020-01720-7","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T23:05:58Z","timestamp":1602111958000},"page":"902-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A review of the role of genetic factors in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"71","author":[{"given":"Amin","family":"Safa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"1720_CR1","doi-asserted-by":"crossref","unstructured":"Ali ZPM, Taheri M, Sangsefidi S, Arsang-Jang S, Mazdeh M, Zamani A, Ghafouri-Fard S, Eftekharian MM (2020) Evaluation of expression of STAT genes in immune-mediated polyneuropathies. J Mol Neurosci 70(6):945\u2013952","DOI":"10.1007\/s12031-020-01494-y"},{"key":"1720_CR2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.41.8.1302","volume":"41","author":"S Bansil","year":"1991","unstructured":"Bansil S, Mithen F, Cook S, Sheffet A, Rohowsky-Kochan C (1991) Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain\u2013Barr\u00e9 syndrome. Neurology 41:1302\u20131302","journal-title":"Neurology"},{"key":"1720_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0972-2327.104341","volume":"15","author":"M Barzegar","year":"2012","unstructured":"Barzegar M, Rouhi AHJ, Farhoudi M, Sardashti S (2012) A report of a probable case of familial Guillain\u2013Barr\u00e9 syndrome. Ann Indian Acad Neurol 15:299","journal-title":"Ann Indian Acad Neurol"},{"key":"1720_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns5.12074","volume":"19","author":"S Blum","year":"2014","unstructured":"Blum S, Mccombe PA (2014) Genetics of Guillain\u2013Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. J Peripher Nerv Syst 19:88\u2013103","journal-title":"J Peripher Nerv Syst"},{"key":"1720_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jns5.12045","volume":"18","author":"S Blum","year":"2013","unstructured":"Blum S, Reddel S, Spies J, Mccombe P (2013) Clinical features of patients with Guillain\u2013Barr\u00e9 syndrome at seven hospitals on the East Coast of Australia. J Peripher Nerv Syst 18:316\u2013320","journal-title":"J Peripher Nerv Syst"},{"key":"1720_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.12.007","volume":"267","author":"S Blum","year":"2014","unstructured":"Blum S, Csurhes P, Reddel S, Spies J, Mccombe P (2014) Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 267:92\u201396","journal-title":"J Neuroimmunol"},{"key":"1720_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jneuroim.2018.07.016","volume":"323","author":"S Blum","year":"2018","unstructured":"Blum S, Ji Y, Pennisi D, Li Z, Leo P, Mccombe P, Brown MA (2018) Genome-wide association study in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 323:109\u2013114","journal-title":"J Neuroimmunol"},{"key":"1720_CR8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1684\/ecn.2019.0436","volume":"30","author":"G Breville","year":"2019","unstructured":"Breville G, Lascano AM, Roux-Lombard P, Lalive PH (2019) IL-8 as a potential biomarker in Guillain\u2013Barr\u00e9 syndrome. Eur Cytokine Netw 30:130\u2013134","journal-title":"Eur Cytokine Netw"},{"key":"1720_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","volume":"177","author":"CM Caporale","year":"2006","unstructured":"Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A (2006) Susceptibility to Guillain\u2013Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol 177:112\u2013118","journal-title":"J Neuroimmunol"},{"key":"1720_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1993.tb04081.x","volume":"87","author":"M Chalon","year":"1993","unstructured":"Chalon M, Sindic C, Laterre E-C (1993) Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal. Acta Neurol Scand 87:77\u201382","journal-title":"Acta Neurol Scand"},{"key":"1720_CR11","doi-asserted-by":"crossref","first-page":"e29506","DOI":"10.1371\/journal.pone.0029506","volume":"7","author":"K-H Chang","year":"2012","unstructured":"Chang K-H, Chuang T-J, Lyu R-K, Ro L-S, Wu Y-R, Chang H-S, Huang C-C, Kuo H-C, Hsu W-C, Chu C-C (2012) Identification of gene networks and pathways associated with Guillain\u2013Barr\u00e9 syndrome. PLoS One 7:e29506","journal-title":"PLoS One"},{"key":"1720_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2016.07.013","volume":"461","author":"K-H Chang","year":"2016","unstructured":"Chang K-H, Lyu R-K, Ro Y-S, Chen Y-C, Ro L-S, Chang H-S, Huang C-C, Liao M-F, Wu Y-R, Kuo H-C (2016) Increased serum concentrations of transforming growth factor-\u03b21 (TGF-\u03b21) in patients with Guillain\u2013Barr\u00e9 syndrome. Clin Chim Acta 461:8\u201313","journal-title":"Clin Chim Acta"},{"key":"1720_CR13","unstructured":"Cornejo-Olivas M, Valdivia-Silva J, Poterico JA, Sanchez C, Hidalgo M, Villanueva I, Jaramillo-Valverde L, Mazzetti P, Levano KS, Cornejo M (2019) Guillain\u2013Barr\u00e9 syndrome outbreak in Peru: association with polymorphisms in IL-17, ICAM1, and CD1. Mol Genet Genomic Med 7(10):e00960"},{"key":"1720_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","volume":"68","author":"A Creange","year":"1996","unstructured":"Creange A, Belec L, Clair B, Rapha\u00ebl J-C, Gherardi R (1996) Circulating tumor necrosis factor (TNF)-\u03b1 and soluble TNF-\u03b1 receptors in patients with Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 68:95\u201399","journal-title":"J Neuroimmunol"},{"key":"1720_CR15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.53.8.1683","volume":"53","author":"A Creange","year":"1999","unstructured":"Creange A, Sharshar T, Planchenault T, Christov C, Poron F, Raphael J-C, Gherardi R (1999) Matrix metalloproteinase-9 is increased and correlates with severity in Guillain\u2013Barr\u00e9 syndrome. Neurology 53:1683\u20131683","journal-title":"Neurology"},{"key":"1720_CR16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","volume":"76","author":"P Csurhes","year":"2005","unstructured":"Csurhes P, Sullivan A, Green K, Pender M, Mccombe P (2005) T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 76:1431\u20131439","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1720_CR17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-510X(97)00178-0","volume":"153","author":"C Dahle","year":"1997","unstructured":"Dahle C, Ekerfelt C, Vrethem M, Samuelsson M, Ernerudh J (1997) T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain\u2013Barr\u00e9 syndrome. J Neurol Sci 153:54\u201360","journal-title":"J Neurol Sci"},{"key":"1720_CR18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0463.2003.apm1111204.x","volume":"111","author":"C Dahle","year":"2003","unstructured":"Dahle C, Kvarnstr\u00f6m M, Ekerfelt C, Samuelsson M, Ernerudh J (2003) Elevated number of cells secreting transforming growth factor \u03b2 in Guillain\u2013Barr\u00e9 syndrome. Apmis 111:1095\u20131104","journal-title":"Apmis"},{"key":"1720_CR19","doi-asserted-by":"crossref","first-page":"577388","DOI":"10.1016\/j.jneuroim.2020.577388","volume":"348","author":"A Das","year":"2020","unstructured":"Das A, Khurshid S, Hayat S, Ahmed R, Islam Z (2020) Glucocorticoid receptor gene polymorphisms in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 348:577388","journal-title":"J Neuroimmunol"},{"key":"1720_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2018.08.001","volume":"323","author":"M Debnath","year":"2018","unstructured":"Debnath M, Nagappa M, Subbanna M, Sundaravadivel P, Talukdar PM, Shivakumar V, Wahatule R, Dutta D, Binukumar B, Sinha S (2018a) Th17 pathway signatures in a large Indian cohort of Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 323:125\u2013130","journal-title":"J Neuroimmunol"},{"key":"1720_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","volume":"110","author":"M Debnath","year":"2018","unstructured":"Debnath M, Nagappa M, Talukdar PM, Subbanna M, Sundaravadivel P, Shivakumar V, Dutta D, Wahatule R, Sinha S, Bindu PS (2018b) Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain\u2013Barr\u00e9 syndrome. Cytokine 110:58\u201362","journal-title":"Cytokine"},{"key":"1720_CR22","doi-asserted-by":"crossref","unstructured":"Debnath M, Nagappa M, Dutta D, Talukdar PM, Subbanna M, Shivakumar V, Wahatule R, Sinha S, Bindu PS, Periyavan S (2020) Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain\u2013Barr\u00e9 syndrome. J Clin Neurosci 75:176\u2013180","DOI":"10.1016\/j.jocn.2020.03.010"},{"key":"1720_CR23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2004.09.015","volume":"159","author":"M Demestre","year":"2005","unstructured":"Demestre M, Parkin-Smith G, Petzold A, Pullen A (2005) The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 159:146\u2013154","journal-title":"J Neuroimmunol"},{"key":"1720_CR24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","volume":"15","author":"H Deng","year":"2008","unstructured":"Deng H, Yang X, Jin T, Wu J, Hu LS, Chang M, Sun XJ, Adem A, Winblad B, Zhu J (2008) The role of IL-12 and TNF-\u03b1 in AIDP and AMAN. Eur J Neurol 15:1100\u20131105","journal-title":"Eur J Neurol"},{"key":"1720_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0029-1237720","volume":"40","author":"A Desurkar","year":"2009","unstructured":"Desurkar A, Lin J-P, Mills K, Al-Sarraj S, Jan W, Jungbluth H, Wraige E (2009) Charcot\u2013Marie\u2013Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children. Neuropediatrics 40:85\u201388","journal-title":"Neuropediatrics"},{"key":"1720_CR26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.4049\/jimmunol.1502100","volume":"196","author":"E Doncel-P\u00e9rez","year":"2016","unstructured":"Doncel-P\u00e9rez E, Mateos-Hern\u00e1ndez L, Pareja E, Garc\u00eda-Forcada \u00c1, Villar M, Tobes R, Ganuza FR, Del Sol VV, Ramos R, De Mera IGF (2016) Expression of early growth response gene-2 and regulated cytokines correlates with recovery from Guillain\u2013Barr\u00e9 syndrome. J Immunol 196:1102\u20131107","journal-title":"J Immunol"},{"key":"1720_CR27","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3892\/mmr.2015.3730","volume":"12","author":"Y Du","year":"2015","unstructured":"Du Y, Zhang G, Zhang Z, Wang Q, Ma R, Zhang L, Fan F, Li Y, Wang M, Lv H (2015) Toll-like receptor 2 and-4 are involved in the pathogenesis of the Guillain\u2013Barr\u00e9 syndrome. Mol Med Rep 12:3207\u20133213","journal-title":"Mol Med Rep"},{"key":"1720_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/clin.1998.4573","volume":"88","author":"RA Elkarim","year":"1998","unstructured":"Elkarim RA, Dahle C, Mustafa M, Press R, Zou L-P, Ekerfelt C, Ernerudh J, Link H, Bakhiet M (1998) Recovery from Guillain\u2013Barr\u00e9 syndrome Is associated with increased levels of neutralizing autoantibodies to interferon-\u03b3. Clin Immunol Immunopathol 88:241\u2013248","journal-title":"Clin Immunol Immunopathol"},{"key":"1720_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clineuro.2014.03.014","volume":"121","author":"N Fekih-Mrissa","year":"2014","unstructured":"Fekih-Mrissa N, Mrad M, Riahi A, Sayeh A, Zaouali J, Gritli N, Mrissa R (2014) Association of HLA-DR\/DQ polymorphisms with Guillain\u2013Barr\u00e9 in Tunisian patients. Clin Neurol Neurosurg 121:19\u201322","journal-title":"Clin Neurol Neurosurg"},{"key":"1720_CR30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/01.WNL.0000143055.09646.31","volume":"63","author":"K Geleijns","year":"2004","unstructured":"Geleijns K, Brouwer B, Jacobs B, Houwing-Duistermaat J, Van Duijn C, Van Doorn P (2004) The occurrence of Guillain\u2013Barr\u00e9 syndrome within families. Neurology 63:1747\u20131750","journal-title":"Neurology"},{"key":"1720_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","volume":"64","author":"K Geleijns","year":"2005","unstructured":"Geleijns K, Schreuder GMT, Jacobs BC, Sintnicolaas K, Van Koningsveld R, Meulstee J, Laman JD, Van Doorn PA (2005) HLA class II alleles are not a general susceptibility factor in Guillain\u2013Barr\u00e9 syndrome. Neurology 64:44\u201349","journal-title":"Neurology"},{"key":"1720_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","volume":"190","author":"K Geleijns","year":"2007","unstructured":"Geleijns K, Emonts M, Laman JD, Van Rijs W, Van Doorn PA, Hermans PW, Jacobs BC (2007) Genetic polymorphisms of macrophage-mediators in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 190:127\u2013130","journal-title":"J Neuroimmunol"},{"key":"1720_CR33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness J, Mccombe PA (2008) Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barr\u00e9 syndrome patients compared to controls. J Clin Neurosci 15:1031\u20131035","journal-title":"J Clin Neurosci"},{"key":"1720_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.40.2.215","volume":"40","author":"H-P Hartung","year":"1990","unstructured":"Hartung H-P, Hughes R, Taylor W, Heininger K, Reiners K, Toyka K (1990) T cell activation in Guillain\u2013Barr\u00e9 syndrome and in MS: Elevated serum levels of soluble IL-2 receptors. Neurology 40:215\u2013215","journal-title":"Neurology"},{"key":"1720_CR35","first-page":"301","volume":"19","author":"ZN Hasan","year":"2014","unstructured":"Hasan ZN, Zalzala HH, Mohammedsalih HR, Mahdi BM, Abid LA, Shakir ZN, Fadhel MJ (2014) Association between human leukocyte antigen-DR and demylinating Guillain\u2013Barr\u00e9 syndrome. Neurosciences (Riyadh) 19:301\u2013305","journal-title":"Neurosciences (Riyadh)"},{"key":"1720_CR36","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acn3.50884","volume":"6","author":"S Hayat","year":"2019","unstructured":"Hayat S, Jahan I, Das A, Hassan Z, Howlader ZH, Mahmud I, Deen Mohammad Q, Islam Z (2019) Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain\u2013Barr\u00e9 syndrome. Ann Clin Trans Neurol 6:1849\u20131857","journal-title":"Ann Clin Trans Neurol"},{"key":"1720_CR37","doi-asserted-by":"crossref","unstructured":"Hayat S, Ahmad O, Mahmud I, Howlader MZH, Islam Z (2020) Association of matrix metalloproteinase-9 polymorphism with severity of Guillain\u2013Barr\u00e9 syndrome. J Neurol Sci 415:116908","DOI":"10.1016\/j.jns.2020.116908"},{"key":"1720_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-5728(98)00053-8","volume":"87","author":"K Hohnoki","year":"1998","unstructured":"Hohnoki K, Inoue A, Koh C-S (1998) Elevated serum levels of IFN-\u03b3, IL-4 and TNF-\u03b1\/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 87:27\u201332","journal-title":"J Neuroimmunol"},{"key":"1720_CR39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00603-7","volume":"193","author":"I Horiuchi","year":"2001","unstructured":"Horiuchi I, Ochi H, Murai H, Osoegawa M, Minohara M, Furuya H, Kira J-I (2001) Th2 shift in mononeuritis multiplex and increase of Th2 cells in chronic inflammatory demyelinating polyneuropathy: an intracellular cytokine analysis. J Neurol Sci 193:49\u201352","journal-title":"J Neurol Sci"},{"key":"1720_CR40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneur.63.6.858","volume":"63","author":"W Hu","year":"2006","unstructured":"Hu W, Dehmel T, Pirhonen J, Hartung H-P, Kieseier BC (2006) Interleukin 23 in acute inflammatory demyelination of the peripheral nerve. Arch Neurol 63:858\u2013864","journal-title":"Arch Neurol"},{"key":"1720_CR41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2009.10.001","volume":"217","author":"S Huang","year":"2009","unstructured":"Huang S, Li L, Liang S, Wang W (2009) Conversion of peripheral CD4+ CD25\u2212 T cells to CD4+ CD25+ regulatory T cells by IFN-\u03b3 in patients with Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 217:80\u201384","journal-title":"J Neuroimmunol"},{"key":"1720_CR42","doi-asserted-by":"crossref","first-page":"030006052090484","DOI":"10.1177\/0300060520904842","volume":"48","author":"P Huang","year":"2020","unstructured":"Huang P, Xu M, He X-Y (2020) Correlations between microRNA-146a and immunoglobulin and inflammatory factors in Guillain\u2013Barr\u00e9 syndrome. J Int Med Res 48:0300060520904842","journal-title":"J Int Med Res"},{"key":"1720_CR43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2017.06.005","volume":"310","author":"I Jahan","year":"2017","unstructured":"Jahan I, Ahammad RU, Farzana KS, Khalid MM, Islam MB, Rahman MI, Nahar S, Kabir Y, Mohmmad QD, Islam Z (2017) Tumor necrosis factor-alpha-863C\/A polymorphism is associated with Guillain\u2013Barr\u00e9 syndrome in Bangladesh. J Neuroimmunol 310:46\u201350","journal-title":"J Neuroimmunol"},{"key":"1720_CR44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0165-5728(00)00460-4","volume":"114","author":"S Jander","year":"2001","unstructured":"Jander S, Stoll G (2001) Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 114:253\u2013258","journal-title":"J Neuroimmunol"},{"key":"1720_CR45","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s11033-011-0892-1","volume":"39","author":"H Jiao","year":"2012","unstructured":"Jiao H, Wang W, Wang H, Wu Y, Wang L (2012) Tumor necrosis factor alpha 308 G\/A polymorphism and Guillain\u2013Barr\u00e9 syndrome risk. Mol Biol Rep 39:1537\u20131540","journal-title":"Mol Biol Rep"},{"key":"1720_CR46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2016.07.020","volume":"298","author":"MED Junior","year":"2016","unstructured":"Junior MED, Ferreira LC, Freire-Neto FP, Jeronimo SM (2016) No association between FCGR2A and FCGR3A polymorphisms in Guillain\u2013Barr\u00e9 syndrome in a Brazilian population. J Neuroimmunol 298:160\u2013164","journal-title":"J Neuroimmunol"},{"key":"1720_CR47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/00207454.2016.1231186","volume":"127","author":"N Kharwar","year":"2017","unstructured":"Kharwar N, Prasad K, Singh K, Paliwal V, Modi D (2017) Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain\u2013Barr\u00e9 syndrome. Int J Neurosci 127:680\u2013687","journal-title":"Int J Neurosci"},{"key":"1720_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.410430404","volume":"43","author":"B Kieseier","year":"1998","unstructured":"Kieseier B, Clements J, Pischel H, Wells G, Miller K, Gearing A, Hartung HP (1998) Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 43:427\u2013434","journal-title":"Ann Neurol"},{"key":"1720_CR49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajmg.10725","volume":"113","author":"I Korn-Lubetzki","year":"2002","unstructured":"Korn-Lubetzki I, Argov Z, Raas-Rothschild A, Wirguin I, Steiner I (2002) Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion. Am J Med Genet 113:275\u2013278","journal-title":"Am J Med Genet"},{"key":"1720_CR50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2008.08.013","volume":"205","author":"ML Kuijf","year":"2008","unstructured":"Kuijf ML, Geleijns K, Ennaji N, Van Rijs W, Van Doorn PA, Jacobs BC (2008) Susceptibility to Guillain\u2013Barr\u00e9 syndrome is not associated with CD1A and CD1E gene polymorphisms. J Neuroimmunol 205:110\u2013112","journal-title":"J Neuroimmunol"},{"key":"1720_CR51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","volume":"34","author":"R Kun Han","year":"2014","unstructured":"Kun Han R, Feng Cheng Y, Shan Zhou S, Guo H, Dong He R, Jun Chi L, Ming Zhang L (2014) Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain\u2013Barr\u00e9 syndrome. J Clin Immunol 34:94\u2013103","journal-title":"J Clin Immunol"},{"key":"1720_CR52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1085-9489.2005.10309.x","volume":"10","author":"M Kurz","year":"2005","unstructured":"Kurz M, Pischel H, Hartung HP, Kieseier BC (2005) Tumor necrosis factor-\u03b1-converting enzyme is expressed in the inflamed peripheral nervous system. J Peripher Nerv Syst 10:311\u2013318","journal-title":"J Peripher Nerv Syst"},{"key":"1720_CR53","first-page":"429","volume":"113","author":"H Li","year":"2000","unstructured":"Li H, Yuan J, Hao H, Yan Z, Wang S (2000) HLA alleles in patients with Guillain\u2013Barr\u00e9 syndrome. Chin Med J 113:429\u2013432","journal-title":"Chin Med J"},{"key":"1720_CR54","doi-asserted-by":"crossref","unstructured":"Li S, Yu M, Li H, Zhang H, Jiang Y (2012) IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain\u2013Barr\u00e9 syndrome. Mediators Inflamm 2012: 260473","DOI":"10.1155\/2012\/260473"},{"key":"1720_CR55","doi-asserted-by":"crossref","unstructured":"Li C, Zhao P, Sun X, Che Y, Jiang Y (2013) Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain\u2013Barr\u00e9 syndrome. Mediators Inflamm 2013:639712","DOI":"10.1155\/2013\/639712"},{"key":"1720_CR56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10072-019-04063-3","volume":"41","author":"C Li","year":"2020","unstructured":"Li C, Luo T, Cheng Y, Liu S, Qiao L, Wu X, Liu K (2020) The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain\u2013Barr\u00e9 syndrome. Neurol Sci 41:295\u2013303","journal-title":"Neurol Sci"},{"key":"1720_CR57","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/08923973.2012.697469","volume":"34","author":"S-L Liang","year":"2012","unstructured":"Liang S-L, Wang W-Z, Huang S, Wang X-K, Zhang S, Wu Y (2012) Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain\u2013Barr\u00e9 syndrome. Immunopharmacol Immunotoxicol 34:1039\u20131046","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1720_CR58","doi-asserted-by":"crossref","first-page":"e86872","DOI":"10.1371\/journal.pone.0086872","volume":"9","author":"AM Liu","year":"2014","unstructured":"Liu AM, Xu Z, Shek FH, Wong K-F, Lee NP, Poon RT, Chen J, Luk JM (2014) miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. PLoS One 9:e86872","journal-title":"PLoS One"},{"key":"1720_CR59","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/08820139.2015.1043671","volume":"44","author":"H Liu","year":"2015","unstructured":"Liu H, Zhang W, Tian F-F, Kun A, Zhou W-B, Xiao B, Li J (2015) IL-35 Is Involved in the pathogenesis of Guillain\u2013Barr\u00e9 syndrome through Its influence on the function of CD4+ T cells. Immunol Investig 44:566\u2013577","journal-title":"Immunol Investig"},{"key":"1720_CR60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2016.07.029","volume":"369","author":"H Liu","year":"2016","unstructured":"Liu H, Xing Y, Guo Y, Liu P, Zhang H, Xue B, Shou J, Qian J, Peng J, Wang R (2016) Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain\u2013Barr\u00e9 syndrome. J Neurol Sci 369:39\u201342","journal-title":"J Neurol Sci"},{"key":"1720_CR61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2016.10.014","volume":"301","author":"Z Lv","year":"2016","unstructured":"Lv Z, Shi Q, Huang W, Xing C, Hao Y, Feng X, Yang Y, Zhang A, Kong Q, Yuki N (2016) MicroRNA expression profiling in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 301:12\u201315","journal-title":"J Neuroimmunol"},{"key":"1720_CR62","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","volume":"44","author":"J Ma","year":"1998","unstructured":"Ma J, Nishimura M, Mine H, Kuroki S, Nukina M, Ohta M, Saji H, Obayashi H, Kawakami H, Saida T (1998) Genetic contribution of the tumor necrosis factor region in Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 44:815\u2013818","journal-title":"Ann Neurol"},{"key":"1720_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-017-0818-5","volume":"14","author":"MS Maddur","year":"2017","unstructured":"Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F (2017) Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. J Neuroinflammation 14:58","journal-title":"J Neuroinflammation"},{"key":"1720_CR64","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.170.6.3074","volume":"170","author":"EE Magira","year":"2003","unstructured":"Magira EE, Papaioakim M, Nachamkin I, Asbury AK, Li CY, Ho TW, Griffin JW, McKhann GM, Monos DS (2003) Differential distribution of HLA-DQ beta\/DR beta epitopes in the two forms of Guillain\u2013Barr\u00e9 syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP. J Immunol 170:3074\u20133080","journal-title":"J Immunol"},{"key":"1720_CR65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","volume":"47","author":"D Maimone","year":"1993","unstructured":"Maimone D, Annunziata P, Simone I, Livrea P, Guazzi G (1993) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 47:55\u201361","journal-title":"J Neuroimmunol"},{"key":"1720_CR66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0036-1579633","volume":"47","author":"LA Mansour","year":"2016","unstructured":"Mansour LA, Girgis MY, Abdulhay M, Eleinein EIA, Elhawary R, Hanna MOF (2016) Polymorphisms of immunoglobulin G Fc receptors in pediatric Guillain\u2013Barr\u00e9 syndrome. Neuropediatrics 47:151\u2013156","journal-title":"Neuropediatrics"},{"key":"1720_CR67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.07.017","volume":"180","author":"PA Mccombe","year":"2006","unstructured":"Mccombe PA, Csurhes PA, Greer JM (2006) Studies of HLA associations in male and female patients with Guillain\u2013Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neuroimmunol 180:172\u2013177","journal-title":"J Neuroimmunol"},{"key":"1720_CR68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"G Mckhann","year":"1993","unstructured":"Mckhann G, Cornblath D, Griffin J, Ho T, Li C, Jiang Z, Wu H, Zhaori G, Liu Y, Jou L (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333\u2013342","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"1720_CR69","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/513786","volume":"176","author":"DS Monos","year":"1997","unstructured":"Monos DS, Papaioakim M, Ho TW, Li CY, Mckhann GM (1997) Differential distribution of HLA alleles in two forms of Guillain\u2013Barr\u00e9 syndrome. J Infect Dis 176(Suppl 2):S180\u2013S182","journal-title":"J Infect Dis"},{"key":"1720_CR70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0972-2327.93278","volume":"15","author":"KR Naik","year":"2012","unstructured":"Naik KR, Saroja AO, Patil BP (2012) Familial Guillain\u2013Barr\u00e9 syndrome: first Indian report. Ann Indian Acad Neurol 15:44","journal-title":"Ann Indian Acad Neurol"},{"key":"1720_CR71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","volume":"168","author":"F Nicoletti","year":"2005","unstructured":"Nicoletti F, Cr\u00e9ange A, Orlikowski D, Bolgert F, Mangano K, Metz C, Di Marco R, Al Abed Y (2005) Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain\u2013Barr\u00e9 syndrome and experimental allergic neuritis. J Neuroimmunol 168:168\u2013174","journal-title":"J Neuroimmunol"},{"key":"1720_CR72","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/jnr.22514","volume":"88","author":"KK Nyati","year":"2010","unstructured":"Nyati KK, Prasad KN, Verma A, Paliwal VK (2010a) Correlation of matrix metalloproteinases-2 and-9 with proinflammatory cytokines in Guillain\u2013Barr\u00e9 syndrome. J Neurosci Res 88:3540\u20133546","journal-title":"J Neurosci Res"},{"key":"1720_CR73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2009.10.018","volume":"218","author":"KK Nyati","year":"2010","unstructured":"Nyati KK, Prasad KN, Verma A, Singh AK, Rizwan A, Sinha S, Paliwal VK, Pradhan S (2010b) Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain\u2013Barr\u00e9 syndrome in Northern Indian population. J Neuroimmunol 218:116\u2013119","journal-title":"J Neuroimmunol"},{"key":"1720_CR74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","volume":"68","author":"KK Nyati","year":"2011","unstructured":"Nyati KK, Prasad KN, Rizwan A, Verma A, Paliwal VK (2011) TH1 and TH2 response to Campylobacter jejuni antigen in Guillain\u2013Barr\u00e9 syndrome. Arch Neurol 68:445\u2013452","journal-title":"Arch Neurol"},{"key":"1720_CR75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","volume":"7","author":"L Ossege","year":"2000","unstructured":"Ossege L, Sindern E, Voss B, Malin JP (2000) Expression of TNF\u03b1 and TGF\u03b21 in Guillain\u2013Barr\u00e9 syndrome: correlation of a low TNF\u03b1-\/TGF\u03b21-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment. Eur J Neurol 7:17\u201325","journal-title":"Eur J Neurol"},{"key":"1720_CR76","first-page":"1","volume":"8","author":"J Peng","year":"2018","unstructured":"Peng J, Zhang H, Liu P, Chen M, Xue B, Wang R, Shou J, Qian J, Zhao Z, Xing Y (2018) IL-23 and IL-27 levels in serum are associated with the process and the recovery of Guillain\u2013Barr\u00e9 syndrome. Sci Rep 8:1\u201310","journal-title":"Sci Rep"},{"key":"1720_CR77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","volume":"71","author":"KN Prasad","year":"2010","unstructured":"Prasad KN, Nyati KK, Verma A, Rizwan A, Paliwal VK (2010) Tumor necrosis factor\u2013\u03b1 polymorphisms and expression in Guillain\u2013Barr\u00e9 syndrome. Hum Immunol 71:905\u2013910","journal-title":"Hum Immunol"},{"key":"1720_CR78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(00)00388-X","volume":"112","author":"R Press","year":"2001","unstructured":"Press R, Deretzi G, Zou L, Zhu J, Fredman P, Lycke J, Link H, Andersson M, Toft J, Larsson A (2001) IL-10 and IFN-\u03b3 in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 112:129\u2013138","journal-title":"J Neuroimmunol"},{"key":"1720_CR79","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","volume":"58","author":"R Press","year":"2002","unstructured":"Press R, Ozenci V, Kouwenhoven M, Link H (2002) Non-TH1 cytokines are augmented systematically early in Guillain\u2013Barr\u00e9 syndrome. Neurology 58:476\u2013478","journal-title":"Neurology"},{"key":"1720_CR80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jneuroim.2006.12.002","volume":"183","author":"J Pritchard","year":"2007","unstructured":"Pritchard J, Makowska A, Gregson NA, Hayday AC, Hughes RA (2007) Reduced circulating CD4+ CD25+ cell populations in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 183:232\u2013238","journal-title":"J Neuroimmunol"},{"key":"1720_CR81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0404.2003.00179.x","volume":"109","author":"V Radhakrishnan","year":"2004","unstructured":"Radhakrishnan V, Sumi M, Reuben S, Mathai A, Nair M (2004) Serum tumour necrosis factor-\u03b1 and soluble tumour necrosis factor receptors levels in patients with Guillain\u2013Barr\u00e9 syndrome. Acta Neurol Scand 109:71\u201374","journal-title":"Acta Neurol Scand"},{"key":"1720_CR82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.11.013","volume":"314","author":"MI Rahman","year":"2018","unstructured":"Rahman MI, Jahan I, Khalid MM, Jahan I, Ahammad RU, Nahar S, Islam Z (2018) CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain\u2013Barr\u00e9 syndrome in the Bangladeshi population. J Neuroimmunol 314:8\u201312","journal-title":"J Neuroimmunol"},{"key":"1720_CR83","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","volume":"62","author":"JH Rees","year":"1995","unstructured":"Rees JH, Vaughan RW, Kondeatis E, Hughes RA (1995) HLA-class II alleles in Guillain\u2013Barr\u00e9 syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 62:53\u201357","journal-title":"J Neuroimmunol"},{"key":"1720_CR84","first-page":"487","volume":"51","author":"S Reuben","year":"2003","unstructured":"Reuben S, Sumi M, Mathai A, Nair M, Radhakrishnan V (2003) Intravenous immunoglobulin reduces serum tumor necrosis factor a in patients with Guillain\u2013Barr\u00e9 syndrome. Neurol India 51:487","journal-title":"Neurol India"},{"key":"1720_CR85","doi-asserted-by":"crossref","unstructured":"Rezaei S, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020) Increased levels of IL-34 in acquired immune-mediated neuropathies. J Mol Neurosci 2020","DOI":"10.1007\/s12031-020-01634-4"},{"key":"1720_CR86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","volume":"51","author":"PP Sainaghi","year":"2010","unstructured":"Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Naldi P, Molinari R, Monaco F, Avanzi GC (2010) The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain\u2013Barr\u00e9 syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine 51:138\u2013143","journal-title":"Cytokine"},{"key":"1720_CR87","doi-asserted-by":"crossref","unstructured":"Sangsefidi S, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020) High levels of Il-19 in patients with chronic inflammatory demyelinating polyneuropathy. J Mol Neurosci 2020","DOI":"10.1007\/s12031-020-01602-y"},{"key":"1720_CR88","doi-asserted-by":"crossref","unstructured":"Saunders M, Rake M (1965) Familial Guillain\u2013Barr\u00e9 syndrome. Lancet 2::1106\u20131107","DOI":"10.1016\/S0140-6736(65)90067-X"},{"key":"1720_CR89","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00415-016-8237-6","volume":"263","author":"L Schirmer","year":"2016","unstructured":"Schirmer L, Worthington V, Solloch U, Loleit V, Grummel V, Lakdawala N, Grant D, Wassmuth R, Schmidt A, Gebhardt F (2016) Higher frequencies of HLA DQB1* 05: 01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain\u2013Barr\u00e9 syndrome. J Neurol 263:2105\u20132113","journal-title":"J Neurol"},{"key":"1720_CR90","doi-asserted-by":"crossref","unstructured":"Senanayake M, Wanigasinghe J, Gamaethige N, Dissanayake P (2012) A case of possible familial Guillain\u2013Barr\u00e9 syndrome. Ceylon Medical J 55(4):135\u2013136","DOI":"10.4038\/cmj.v55i4.2638"},{"key":"1720_CR91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF00868524","volume":"243","author":"E Sindern","year":"1996","unstructured":"Sindern E, Schweppe K, Ossege LM, Malin JP (1996) Potential role of transforming growth factor-\u03b21 in terminating the immune response in patients with Guillain\u2013Barr\u00e9 syndrome. J Neurol 243:264\u2013268","journal-title":"J Neurol"},{"key":"1720_CR92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0404.2009.01229.x","volume":"122","author":"S Sinha","year":"2010","unstructured":"Sinha S, Prasad KN, Jain D, Nyati KK, Pradhan S, Agrawal S (2010) Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain\u2013Barr\u00e9 syndrome. Acta Neurol Scand 122:21\u201326","journal-title":"Acta Neurol Scand"},{"key":"1720_CR93","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-510X(96)00319-X","volume":"147","author":"S Sivieri","year":"1997","unstructured":"Sivieri S, Ferrarini A, Lolli F, Mat\u00e0 S, Pinto F, Tavolato B, Gallo P (1997) Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 147:93\u201395","journal-title":"J Neurol Sci"},{"key":"1720_CR94","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1073\/pnas.0603912103","volume":"103","author":"S Subramanian","year":"2006","unstructured":"Subramanian S, Tus K, Li Q-Z, Wang A, Tian X-H, Zhou J, Liang C, Bartov G, Mcdaniel LD, Zhou XJ (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci 103:9970\u20139975","journal-title":"Proc Natl Acad Sci"},{"key":"1720_CR95","first-page":"357","volume":"40","author":"H Tekg\u00fcl","year":"1998","unstructured":"Tekg\u00fcl H, K\u00fct\u00fck\u00e7\u00fcler N, Ca\u011flayan S, T\u00fct\u00fcnc\u00fco\u011flu S (1998) Pro-inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in Guillain\u2013Barr\u00e9 syndrome. Turk J Pediatr 40:357\u2013363","journal-title":"Turk J Pediatr"},{"key":"1720_CR96","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","volume":"54","author":"W-L Van Der Pol","year":"2000","unstructured":"Van Der Pol W-L, Van Den Berg L, Scheepers R, Van Der Bom J, Van Doorn P, Van Koningsveld R, Van Den Broek M, Wokke J, Van De Winkel J (2000) IgG receptor IIa alleles determine susceptibility and severity of Guillain\u2013Barr\u00e9 syndrome. Neurology 54:1661\u20131665","journal-title":"Neurology"},{"key":"1720_CR97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","volume":"162","author":"NM Van Sorge","year":"2005","unstructured":"Van Sorge NM, Van Der Pol W-L, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr K-M (2005) Severity of Guillain\u2013Barr\u00e9 syndrome is associated with Fc\u03b3 receptor III polymorphisms. J Neuroimmunol 162:157\u2013164","journal-title":"J Neuroimmunol"},{"key":"1720_CR98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","volume":"55","author":"CA Vedeler","year":"2000","unstructured":"Vedeler CA, Raknes G, Myhr KM, Nyland H (2000) IgG Fc-receptor polymorphisms in Guillain\u2013Barr\u00e9 syndrome. Neurology 55:705\u2013707","journal-title":"Neurology"},{"key":"1720_CR99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000328200","volume":"19","author":"Y-Z Wang","year":"2012","unstructured":"Wang Y-Z, Liang Q-H, Ramkalawan H, Wang Y-L, Yang Y-F, Zhou W-B, Tian F-F, Li J, Yang H (2012) Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain\u2013Barr\u00e9 syndrome. Neuroimmunomodulation 19:60\u201368","journal-title":"Neuroimmunomodulation"},{"key":"1720_CR100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10753-012-9551-5","volume":"36","author":"Y-Z Wang","year":"2013","unstructured":"Wang Y-Z, Feng X-G, Shi Q-G, Hao Y-L, Yang Y, Zhang A-M, Kong Q-X (2013a) Silencing of miR155 promotes the production of inflammatory mediators in Guillain\u2013Barr\u00e9 syndrome in vitro. Inflammation 36:337\u2013345","journal-title":"Inflammation"},{"key":"1720_CR101","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.01.006","volume":"257","author":"Y-Z Wang","year":"2013","unstructured":"Wang Y-Z, Tian F-F, Liu H, Zhang W, Li J, Xiao B, Zhou W-B (2013b) Macrophage migration inhibitory factor is necessary for the lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients. J Neuroimmunol 257:67\u201375","journal-title":"J Neuroimmunol"},{"key":"1720_CR102","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2011.12.003","volume":"243","author":"L-Y Wu","year":"2012","unstructured":"Wu L-Y, Zhou Y, Qin C, Hu B-L (2012) The effect of TNF-alpha, Fc\u03b3R and CD1 polymorphisms on Guillain\u2013Barr\u00e9 syndrome risk: evidences from a meta-analysis. J Neuroimmunol 243:18\u201324","journal-title":"J Neuroimmunol"},{"key":"1720_CR103","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1038\/srep21819","volume":"6","author":"J Xu","year":"2016","unstructured":"Xu J, Gao C, Zhang F, Ma X, Peng X, Zhang R, Kong D, Simard AR, Hao J (2016) Differentially expressed lncRNAs and mRNAs identified by microarray analysis in GBS patients vs healthy controls. Sci Rep 6:21819","journal-title":"Sci Rep"},{"key":"1720_CR104","first-page":"531","volume":"126","author":"P-Q Yin","year":"2016","unstructured":"Yin P-Q, Sun Y-Y, Chen H-P, Li G-Z, Zhong D (2016) Genome-wide gene expression analysis of peripheral leukocytes in relation to the male predominance of Guillain\u2013Barr\u00e9 syndrome: differential gene expression between male and female patients. Int J Neurosci 126:531\u2013541","journal-title":"Int J Neurosci"},{"key":"1720_CR105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1468-1331.2000.00072.x","volume":"7","author":"F Yoshii","year":"2000","unstructured":"Yoshii F, Shinohara Y (2000) Impaired interleukin-2 response of mononuclear cells in Guillain\u2013Barr\u00e9 syndrome. Eur J Neurol 7:303\u2013307","journal-title":"Eur J Neurol"},{"key":"1720_CR106","first-page":"332","volume":"20","author":"X Zhang","year":"2000","unstructured":"Zhang X, Xia J, Ye H (2000) Effect of Tripterygium polyglycoside on interleukin-6 in patients with Guillain\u2013Barr\u00e9 syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 20:332\u2013334 (Chinese journal of integrated traditional and Western medicine)","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"1720_CR107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","volume":"58","author":"J Zhang","year":"2007","unstructured":"Zhang J, Dong H, Li B, Li C-Y, Guo L (2007) Association of tumor necrosis factor polymorphisms with Guillain\u2013Barr\u00e9 syndrome. Eur Neurol 58:21\u201325","journal-title":"Eur Neurol"},{"key":"1720_CR108","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"H-L Zhang","year":"2013","unstructured":"Zhang H-L, Zheng X-Y, Zhu J (2013) Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 24:443\u2013453","journal-title":"Cytokine Growth Factor Rev"},{"key":"1720_CR109","doi-asserted-by":"crossref","first-page":"21890","DOI":"10.1038\/srep21890","volume":"6","author":"D-Q Zhang","year":"2016","unstructured":"Zhang D-Q, Wang R, Li T, Zhou J-P, Chang G-Q, Zhao N, Yang L-N, Zhai H, Yang L (2016) Reduced soluble RAGE is associated with disease severity of axonal Guillain\u2013Barr\u00e9 syndrome. Sci Rep 6:21890","journal-title":"Sci Rep"},{"key":"1720_CR110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2017.02.003","volume":"468","author":"L-J Zhang","year":"2017","unstructured":"Zhang L-J, Guo H-Y, Zhang D-Q, Wang R, Li T, Li L-M, Suo D-M, Yang L (2017) Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain\u2013Barr\u00e9 syndrome. Clin Chim Acta 468:5\u20139","journal-title":"Clin Chim Acta"},{"key":"1720_CR111","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s10072-018-3563-3","volume":"39","author":"L Zhang","year":"2018","unstructured":"Zhang L, Liu L, Li H, Guo L, Yu Q, Teng J (2018) Association of CD1 and Fc\u03b3R gene polymorphisms with Guillain\u2013Barr\u00e9 syndrome susceptibility: a meta-analysis. Neurol Sci 39:2141\u20132149","journal-title":"Neurol Sci"},{"key":"1720_CR112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2019.02.011","volume":"330","author":"D-Q Zhang","year":"2019","unstructured":"Zhang D-Q, Deng Y, Zhang L-J, Li L-M, Qi Y, Wang J, Wang R, Zhai H, Zhao P, Yang L (2019) Elevated resistin levels may regulate high mobility group box 1 expression in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 330:59\u201366","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01720-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:53:30Z","timestamp":1698231210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01720-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01720-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"23 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}